KDM1A and metabolic dysfunction-associated steatotic liver disease: In conclusion, our study reveals that KDM1A aggravates liver steatosis and inflammation through increasing the accessibility of chromatin, demonstrating that harnessing chromatin remodeling and epigenetic modifications is crucial for managing NAFLD.